Archive - May 2022
‘Green’ Products For Kids And Adolescents Contain Toxic Chemicals: Study
BioXcel Therapeutics begins phase 3 trial for acute agitation in Alzheimer’s patients
EC approves Novartis’ Kymriah for advanced blood cancer
Novartis Kymriah receives EC approval for lymphoma treatment
Isla Visual Record for Surveillance to aid post-surgery wound assessment
COVID Worsens Asthma In Children; Booster After Infection Not As Beneficial Vs Omicron
Inadequate Diaper Supply Linked To Disrupted, Shorter Sleep In Children
FDA Approves Voquezna Triple Pak (vonoprazan, amoxicillin, clarithromycin) and Voquezna Dual Pak (vonoprazan, amoxicillin) for the Treatment of H. pylori Infection in Adults